Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic β-cell function after 3-week daily administration in obese diabetic (ob/ob) mice

Brian D. Green*, Kerry S. Lavery, Nigel Irwin, Finbarr P.M. O'Harte, Patrick Harriott, Brett Greer, Clifford J. Bailey, Peter R. Flatt

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic β-cell function after 3-week daily administration in obese diabetic (ob/ob) mice'. Together they form a unique fingerprint.

Medicine & Life Sciences